Bank of New York Mellon Corp
BankPosition in UTHR — UNITED THERAPEUTICS Corp
CIK 1390777
NEW YORK, NY
Position in UTHR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$195,178,172
+$32,617,447 QoQ
Shares Held
329,148
-1.3% QoQ
Ownership
0.775%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92.496688419799.ToString("F0")%
Shared 0.006380108644135769.ToString("F0")%
None 7.496931471556868.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,371,862,681 across 46 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in UTHR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $195,178,172 | 329,148 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $162,560,725 | 333,629 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $147,333,443 | 351,455 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $104,156,036 | 362,471 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $123,371,804 | 400,207 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $140,932,761 | 399,424 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $143,740,271 | 401,117 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $138,517,959 | 434,839 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $105,288,250 | 458,333 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $121,790,026 | 553,868 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $128,987,124 | 571,068 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $131,617,767 | 596,230 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $136,649,860 | 610,153 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $160,904,813 | 578,607 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $126,995,664 | 606,532 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $184,013,390 | 780,909 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $149,314,147 | 832,251 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $219,097,550 | 1,013,965 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $155,962,340 | 844,958 | Shares | Other | 2021-11-18 | |
| 2021-06-30 | $129,473,552 | 721,663 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $111,720,130 | 667,903 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $48,993,080 | 485,080 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $59,199,129 | 489,249 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $44,603,855 | 470,356 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||